Additional Proxy Soliciting Materials (definitive) (defa14a)
April 19 2022 - 11:37AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant x
Filed by a party other than the Registrant ¨
Check the appropriate box:
¨ Preliminary
Proxy Statement
¨ Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨ Definitive
Proxy Statement
x Definitive
Additional Materials
¨ Soliciting
Material under § 240.14a-12
Aridis Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
x No fee
required
¨ Fee paid
previously with preliminary materials.
¨ Fee computed
on table in exhibit required by Item 25(b) per Exchange Act Rules 14a- 6(i)(1) and 0-11
| Get informed before you vote
*If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at www.ProxyVote.com or request a
paper copy of the materials, which will contain the appropriate instructions. Please check the meeting materials for any special requirements for meeting attendance.
Smartphone users
Point your camera here and
vote without entering a
control number
Your Vote Counts!
FLASHID-JOB#
For complete information and to vote, visit www.ProxyVote.com
Control #
Ricky Campana
P.O. Box 123456
Suite 500
51 Mercedes Way
Edgewood, NY 11717
1 OF 2 322,224 148,294
30#
Hextone, Inc.
P.O. Box 9142
Farmingdale, NY 11735
XXXX XXXX XXXX XXXX
ARIDIS PHARMACEUTICALS, INC.
2022 Annual Meeting
Vote by June 01, 2022
11:59 PM ET
You invested in ARIDIS PHARMACEUTICALS, INC. and it's time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the
availability of proxy material for the shareholder meeting to be held on June 02, 2022.
View the Form 10-K, Notice & Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting
prior to May 19, 2022. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1)
visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please
include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email
copy.
Vote in Person at the Meeting*
June 02, 2022
9:00 AM PDT
983 University Ave
Bldg. B
Los Gatos, CA 95032 |
| Voting Items
Board
Recommends
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the
upcoming shareholder meeting. Please follow the instructions on
the reverse side to vote these important matters.
Vote at www.ProxyVote.com
FLASHID-JOB#
Control # XXXX XXXX XXXX XXXX
1.00000
322,224
148,294
Under New York Stock Exchange rules, brokers may vote “routine” matters at their discretion if your voting instructions are not communicated
to us at least 10 days before the meeting. We will nevertheless follow your instructions, even if the broker’s discretionary vote has
already been given, provided your instructions are received prior to the meeting date.
ARIDIS PHARMACEUTICALS, INC.
2022 Annual Meeting
Vote by June 01, 2022
11:59 PM ET
1. Election of Directors
Nominees:
1A Craig Gibbs, Ph.D. For
1B John Hamilton For
1C Robert R. Ruffolo, Ph.D For
2 Proposal to ratify Mayer Hoffman McCann P.C. as the Company's independent registered public accountants for
fiscal year ending December 31, 2022. For
3 Non-binding advisory vote to approve the compensation of our Named Executive Officers. For
4 Non-binding advisory vote on the frequency of the vote to approve the compensation of our Named Executive
Officers. Years
5 Proposal to approve the amendment and restatement of the 2014 Equity Incentive Plan. For
NOTE: Such other business as may properly come before the meeting or any adjournment thereof. |
Aridis Pharmaceuticals (NASDAQ:ARDS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aridis Pharmaceuticals (NASDAQ:ARDS)
Historical Stock Chart
From Sep 2023 to Sep 2024